Ubs Asset Management Americas Inc Alaunos Therapeutics, Inc. Transaction History

Ubs Asset Management Americas Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.41 - $1.24 $72,137 - $218,170	-175,944 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.09 - $1.89 $111,180 - $192,780	-102,000 Reduced 36.7%	175,944 $191,000
Q2 2021 Aug 16, 2021	BUY	$2.63 - $3.67 $131,878 - $184,028	50,144 Added 22.01%	277,944 $733,000
Q1 2021 May 14, 2021	BUY	$2.82 - $5.6 $97,391 - $193,401	34,536 Added 17.87%	227,800 $820,000
Q3 2020 Nov 13, 2020	SELL	$2.39 - $3.43 $9,930 - $14,251	-4,155 Reduced 2.1%	193,264 $487,000
Q2 2020 Aug 14, 2020	BUY	$2.2 - $3.71 $85,690 - $144,504	38,950 Added 24.58%	197,419 $647,000
Q1 2020 May 15, 2020	BUY	$1.9 - $4.98 $36,398 - $95,401	19,157 Added 13.75%	158,469 $388,000
Q4 2019 Feb 14, 2020	BUY	$3.95 - $5.35 $168,155 - $227,754	42,571 Added 44.01%	139,312 $657,000
Q3 2019 Nov 14, 2019	BUY	$4.13 - $6.94 $26,832 - $45,089	6,497 Added 7.2%	96,741 $414,000
Q2 2019 Aug 15, 2019	SELL	$3.98 - $6.2 $47,449 - $73,916	-11,922 Reduced 11.67%	90,244 $0
Q1 2019 May 14, 2019	BUY	$2.0 - $4.4 $13,420 - $29,524	6,710 Added 7.03%	102,166 $0
Q4 2018 Feb 13, 2019	BUY	$1.61 - $3.62 $44,944 - $101,055	27,916 Added 41.33%	95,456 $178,000
Q2 2018 Aug 14, 2018	SELL	$3.02 - $4.94 $34,914 - $57,111	-11,561 Reduced 14.62%	67,540 $0
Q1 2018 May 14, 2018	BUY	$3.46 - $5.14 $51,799 - $76,950	14,971 Added 23.34%	79,101 $0
Q4 2017 Feb 09, 2018	BUY	$4.0 - $6.54 $35,200 - $57,552	8,800 Added 15.9%	64,130 $0
Q3 2017 Nov 13, 2017	BUY	$4.99 - $6.57 $276,096 - $363,518	55,330	55,330 $0

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $493M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.